A lack of health equity in clinical trials can have severe effects upon ROI and customer relationships once at market.
Equitable clinical trial design and delivery is essential to properly measure treatment effectiveness and safety for therapies serving global patient populations. While the concept is nothing new to the clinical trial space and progress has certainly been made, sponsors must be intentional when designing clinical trials — from site locations to patient screening criteria — to ensure that patient populations best represent those potentially eligible for their therapies.
Equitable representation beyond races and ethnicity is required; it includes individuals from differing socioeconomic backgrounds, sexual orientations, gender identities, neurodivergences, and physical disabilities in the overall population.
Low diversity within your patient base not only limits revenue potential, but also puts your company’s reputation and relationship with minority populations at risk. Integrating DEI initiatives into your budget, trial strategy, and communication plans is imperative for staying in line with shifting industry regulations and growing patient expectations. To create diverse, highly trusted clinical trials, clinical operation teams must make DEI strategies a priority in the initial planning stages.
Equitable Clinical Trials Solutions
Clinical trials fuel innovation and healthcare solutions, but in order to deliver within the dynamic landscape of clinical trials, incorporation of health equity and equitable clinical trial design is vital. A one-size model doesn’t work, so our consultants leverage a comprehensive approach and work with your team using the below core services to deliver a specialized solution.
Health Equity Assessment & Strategy
We work with you to understand your vision and goals for your clinical trials while also assessing the current state of health equity maturity in your organization and your clinical trial design, developing a comprehensive strategy to improve clinical trial recruitment and retention.
DEI and Cultural Sensitivity Training
Our wide range of trainings and seminars can be tailored to fit the direct needs of the personnel involved in your clinical trials, focusing on educating your team on topics whether the topics like unconscious bias, cultural sensitivity, or even more focused and niche educational topics.
Inclusive Marketing
Our DEI marketing SMEs work with your stakeholders to develop a strategy to improve your marketing tactics for improved patient recruitment as well as support the execution of a holistic, collaborative strategy.
Curious about how to incorporate health equity strategies into your clinical research from the start?
Clinical operations organizations need to incorporate health equity and DEI into clinical trials sooner rather than later. Contact one of our clinical research experts to find out how our DEI solutions can further your clinical trial success.
Would you like to learn more about our DEI practice?
Diversity Action Plans for Clinical Trials
Sponsors should be prepared to submit mandatory diversity action plans for certain late-stage drug trials, including all phase 3 trials and most device studies. The diversity action plan must include the sponsor’s goals for enrollment in the clinical study, the sponsor’s rationale for those goals, and an explanation of how the sponsor intends to meet them.
Learn More Here
Contact Us to Learn More About Our Consulting Services for Health Equity
Click through to contact us online or give us a call or email anytime.
Phone: (919) 484-4400
Email: info@clarkstonconsulting.com